Previous Article | Next Article 
Journal of Virology, July 1999, p. 5381-5387, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Combinatorial Screening and Intracellular Antiviral
Activity of Hairpin Ribozymes Directed against Hepatitis B
Virus
Jasper
zu
Putlitz,1,
Qiao
Yu,2,
John M.
Burke,2 and
Jack R.
Wands1,*
Molecular Hepatology Laboratory,
Massachusetts General Hospital Cancer Center, and Harvard Medical
School, Boston, Massachusetts 02129,1 and
Department of Microbiology and Molecular Genetics, Markey
Center for Molecular Genetics, The University of Vermont, Burlington,
Vermont 054052
Received 1 December 1998/Accepted 13 April 1999
A combinatorial screening method has been used to identify hairpin
ribozymes that inhibit hepatitis B virus (HBV) replication in
transfected human hepatocellular carcinoma (HCC) cells. A hairpin ribozyme library (5 × 105 variants) containing a
randomized substrate-binding domain was used to identify accessible
target sites within 3.3 kb of full-length in vitro-transcribed HBV
pregenomic RNA. Forty potential target sites were found within the HBV
pregenomic RNA, and 17 sites conserved in all four subtypes of HBV were
chosen for intracellular inhibition experiments. Polymerase II and III
promoter expression constructs for corresponding hairpin ribozymes
were generated and cotransfected into HCC cells together with a
replication-competent dimer of HBV DNA. Four ribozymes inhibited
HBV replication by 80, 69, 66, and 49%, respectively, while
catalytically inactive mutant forms of these ribozymes affected HBV
replication by 36, 28, 0, and 0%. These findings indicate that the
inhibitory effects on HBV replication were largely mediated by the
catalytic activity of the ribozymes. In conclusion, we have
identified catalytically active RNAs by combinatorial screening that
mediate intracellular antiviral effects on HBV.
*
Corresponding author. Mailing address: The Liver
Research Center, 55 Claverick St., 4th Floor, Providence, RI 02903. Phone: (401) 444-2795. Fax: (401) 444-2939. E-mail: Jack Wands
MD{at}Brown.edu.

Present address: Department of Internal Medicine, University of
Freiburg, 79106 Freiburg,
Germany.

Present address: Genetic Therapy, Inc., Gaithersburg, MD
20878.
Journal of Virology, July 1999, p. 5381-5387, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yang, Y.-H., Li, H., Zhou, T., Kim, K., Liu, F.
(2006). Engineered external guide sequences are highly effective in inducing RNase P for inhibition of gene expression and replication of human cytomegalovirus. Nucleic Acids Res
34: 575-583
[Abstract]
[Full Text]
-
Zhang, Z., Burke, J. M.
(2005). Inhibition of Viral Replication by Ribozyme: Mutational Analysis of the Site and Mechanism of Antiviral Activity. J. Virol.
79: 3728-3736
[Abstract]
[Full Text]
-
Deocaris, C. C., Kaul, S. C., Taira, K., Wadhwa, R.
(2004). Emerging Technologies: Trendy RNA Tools for Aging Research. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
59: B771-B783
[Abstract]
[Full Text]
-
Zou, H., Lee, J., Kilani, A. F., Kim, K., Trang, P., Kim, J., Liu, F.
(2004). Engineered RNase P Ribozymes Increase Their Cleavage Activities and Efficacies in Inhibiting Viral Gene Expression in Cells by Enhancing the Rate of Cleavage and Binding of the Target mRNA. J. Biol. Chem.
279: 32063-32070
[Abstract]
[Full Text]
-
Kim, K., Trang, P., Umamoto, S., Hai, R., Liu, F.
(2004). RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins. Nucleic Acids Res
32: 3427-3434
[Abstract]
[Full Text]
-
Zou, H., Lee, J., Umamoto, S., Kilani, A. F., Kim, J., Trang, P., Zhou, T., Liu, F.
(2003). Engineered RNase P Ribozymes Are Efficient in Cleaving a Human Cytomegalovirus mRNA in Vitro and Are Effective in Inhibiting Viral Gene Expression and Growth in Human Cells. J. Biol. Chem.
278: 37265-37274
[Abstract]
[Full Text]
-
Karayiannis, P.
(2003). Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother
51: 761-785
[Abstract]
[Full Text]
-
Bergeron, L. J., Perreault, J.-P.
(2002). Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus. Nucleic Acids Res
30: 4682-4691
[Abstract]
[Full Text]
-
Zhou, T., Kim, J., Kilani, A. F., Kim, K., Dunn, W., Jo, S., Nepomuceno, E., Liu, F.
(2002). In Vitro Selection of External Guide Sequences for Directing RNase P-mediated Inhibition of Viral Gene Expression. J. Biol. Chem.
277: 30112-30120
[Abstract]
[Full Text]
-
Seyhan, A. A., Vitiello, D., Shields, M. T., Burke, J. M.
(2002). Ribozyme Inhibition of Alphavirus Replication. J. Biol. Chem.
277: 25957-25962
[Abstract]
[Full Text]
-
Trang, P., Lee, J., Kilani, A. F., Kim, J., Liu, F.
(2001). Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme. Nucleic Acids Res
29: 5071-5078
[Abstract]
[Full Text]
-
Kruger, M., Beger, C., Welch, P. J., Barber, J. R., Wong-Staal, F.
(2001). C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification. Nucleic Acids Res
29: e94-e94
[Abstract]
[Full Text]
-
Mir, A. A., Lockett, T. J., Hendry, P.
(2001). Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers. Nucleic Acids Res
29: 1906-1914
[Abstract]
[Full Text]
-
Bramlage, B., Luzi, E., Eckstein, F.
(2000). HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture. Nucleic Acids Res
28: 4059-4067
[Abstract]
[Full Text]
-
Kilani, A. F., Trang, P., Jo, S., Hsu, A., Kim, J., Nepomuceno, E., Liou, K., Liu, F.
(2000). RNase P Ribozymes Selected in Vitro to Cleave a Viral mRNA Effectively Inhibit Its Expression in Cell Culture. J. Biol. Chem.
275: 10611-10622
[Abstract]
[Full Text]